PROVENTION BIO INC (PRVB)
US74374N1028 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to PRVB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is -2% below the current price.
PRVB was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PRVB.
In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
PRVB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-14 | SMBC Nikko | Downgrade | Outperform -> Neutral |
| 2023-03-14 | Jefferies | Downgrade | Buy -> Hold |
| 2023-03-13 | Chardan Capital | Maintains | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-21 | Chardan Capital | Maintains | Buy |
| 2022-11-21 | SVB Leerink | Maintains | Outperform |
| 2022-11-18 | Oppenheimer | Maintains | Outperform |
| 2022-11-18 | Jefferies | Maintains | Buy |
| 2022-11-04 | Chardan Capital | Maintains | Buy |
| 2022-10-07 | Jefferies | Maintains | Buy |
| 2022-09-20 | Jefferies | Initiate | Buy |
| 2022-08-05 | Chardan Capital | Maintains | Buy |
| 2022-07-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-06 | Oppenheimer | Maintains | Outperform |
| 2021-08-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-13 | Chardan Capital | Maintains | Buy |
| 2021-04-12 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-04-09 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-04-09 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2021-04-09 | SVB Leerink | Maintains | Outperform |
| 2021-02-22 | HC Wainwright & Co. | Maintains | Buy |